Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective Study

PURPOSE: Advanced clear cell sarcoma (CCS) is a rare subtype of sarcoma with few effective treatments. Evidence shows that apatinib is efficacious and safe for CCS. This study aimed to assess the safety and efficacy of apatinib and/or camrelizumab (a PD-1 inhibitor) in treating advanced CCS. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiaqiang, Gao, Shilei, Yang, Yonghao, Liu, Xu, Zhang, Peng, Dong, Shuping, Wang, Xin, Yao, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650770/
https://www.ncbi.nlm.nih.gov/pubmed/34887682
http://dx.doi.org/10.2147/CMAR.S337253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650770/
https://www.ncbi.nlm.nih.gov/pubmed/34887682
http://dx.doi.org/10.2147/CMAR.S337253

Ejemplares similares